 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/18/2024 |
$41.72 |
$41.72 |
$39.59 |
$40.31 |
324.10K | | 04/19/2024 |
$40.48 |
$41.26 |
$39.01 |
$39.88 |
362.90K | | 04/22/2024 |
$39.92 |
$40.31 |
$39.18 |
$40.01 |
395.00K | | 04/23/2024 |
$40.23 |
$41.59 |
$39.52 |
$41.09 |
323.50K | | 04/24/2024 |
$41.16 |
$41.16 |
$39.24 |
$39.50 |
325.60K |
|
|
| Xenon Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing therapeutics for patients with neurological disorders. Co.'s product pipeline of neurology-focused therapies focus on epilepsy. Co.'s product candidates include: XEN1101, a Kv7 potassium channel opener for the treatment of epilepsy and potentially other neurological disorders, such as major depressive disorder; and XEN496, a Kv7 potassium channel opener for the treatment of KCNQ2 developmental and epileptic encephalopathy. In addition, Co. has a license and collaboration agreement with Neurocrine Biosciences Inc. to develop NBI-921352, a Nav1.6 sodium channel inhibitor for the treatment of epilepsy. | |
|
Xenon Pharmaceuticals (XENE) has the following price history information. Looking back at XENE historical stock prices for the last five trading days, on April 18, 2024, XENE opened at $41.72, traded as high as $41.72 and as low as $39.59, and closed at $40.31. Trading volume was a total of 324.10K shares. On April 19, 2024, XENE opened at $40.48, traded as high as $41.26 and as low as $39.01, and closed at $39.88. Trading volume was a total of 362.90K shares. On April 22, 2024, XENE opened at $39.92, traded as high as $40.31 and as low as $39.18, and closed at $40.01. Trading volume was a total of 395.00K shares. On April 23, 2024, XENE opened at $40.23, traded as high as $41.59 and as low as $39.52, and closed at $41.09. Trading volume was a total of 323.50K shares. On April 24, 2024, XENE opened at $41.16, traded as high as $41.16 and as low as $39.24, and closed at $39.50. Trading volume was a total of 325.60K shares.
XENE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Xenon Pharmaceuticals shares, starting with a $10,000 purchase of XENE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
11/07/2014 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$13.29 |
|
| End price/share: |
$39.50 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
197.22% |
|
| Average Annual Total Return: |
12.20% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$29,731.72 |
|
| Years: |
9.47 |
|
|
|
| Date |
Close |
| 04/18/2024 | $40.31 | | 04/19/2024 | $39.88 | | 04/22/2024 | $40.01 | | 04/23/2024 | $41.09 | | 04/24/2024 | $39.50 |
|
|
